DAHANCA 10 – Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
To evaluate if correction of low hemoglobin (Hb) levels by means of darbepoetin alfa improves the outcomes of radiotherapy in patients with squamous cell carcinoma of the head and neck (HNSCC).
Source: Radiotherapy and Oncology - Category: Radiology Authors: Jens Overgaard, Camilla Molich Hoff, Hanne Sand Hansen, Lena Specht, Marie Overgaard, Pernille Lassen, Elo Andersen, J ørgen Johansen, Lisbeth Juhler Andersen, Jan Folkvard Evensen, Jan Alsner, Cai Grau Tags: Original article Source Type: research
More News: Aranesp | Cancer | Cancer & Oncology | Carcinoma | Denmark Health | Head and Neck Cancer | HNSCC | Radiology | Skin Cancer | Squamous Cell Carcinoma